Somewhere in the intake form for almost every psilocybin retreat you'll find a section that quietly asks about your current medications. Most people gloss over it. They shouldn't. If you're on antidepressants — SSRIs, SNRIs, tricyclics, MAOIs, lithium, bupropion, or one of the newer additions to the psychiatric shelf — the interaction between your prescription and a ceremonial dose of psilocybin is one of the most important conversations you'll have before you ever sit in circle.

This isn't a moralizing piece about staying on or coming off medication. That's between you and a prescriber who actually knows you. What this is — is a plain-English walkthrough of what happens biochemically, what facilitators tend to require, what the risks actually look like, and how to think about all of it without either panicking or shrugging it off. If you're considering a psychedelic retreat and you take something daily to manage depression, anxiety, or a mood disorder, keep reading. This one matters.

Why the Interaction Question Even Comes Up

Psilocybin, once metabolized into psilocin, works largely by binding to serotonin 2A receptors in the brain. That's the same neurotransmitter system most antidepressants target — just from a very different angle. SSRIs (Prozac, Zoloft, Lexapro, Celexa) keep more serotonin floating in the synapse. SNRIs (Effexor, Cymbalta) do the same for serotonin and norepinephrine. MAOIs prevent the breakdown of serotonin altogether. When you introduce a serotonergic psychedelic into a system that's already been chemically retuned around serotonin, you get a collision of pharmacology that behaves differently depending on which medication is in the mix.

The most-repeated concern in retreat circles is attenuation — the psychedelic experience gets muted, sometimes to the point of feeling nothing at all. Your receptors, in effect, have been sitting in a bath of serotonin for months or years and have downregulated. Psilocin arrives, knocks on the door, and the door barely opens. Participants pay thousands of dollars, fly to Peru or the Netherlands or Jamaica, drink the tea or eat the mushrooms, and report a mild body sensation and not much else. It's a real phenomenon, and it's the reason many retreats won't accept guests still actively taking SSRIs.

Attenuation is the disappointing outcome. The dangerous one is serotonin syndrome — a rare but serious condition where serotonin levels spike beyond what the body can handle. Symptoms range from sweating and confusion to muscle rigidity, seizures, and, in extreme cases, death. The higher-risk combinations involve MAOIs (which is why ayahuasca is a hard no with most antidepressants — the vine itself contains MAOIs) but tricyclics and certain SNRIs also raise the risk profile.

Which Medications Cause Which Problems

The details matter more than most blog posts admit. Here's a rough map of the terrain:

• SSRIs (Prozac, Zoloft, Lexapro, Celexa, Paxil): usually dampen the psilocybin experience. Serotonin syndrome risk is considered low but not zero. Most reputable retreats ask for a taper of 2–6 weeks off before ceremony, depending on the drug's half-life. Fluoxetine (Prozac) has a very long half-life and often needs the longest washout.
• SNRIs (Effexor, Cymbalta, Pristiq): similar attenuation issue, slightly higher pharmacological complexity. Tapering is medically supervised territory — Effexor in particular has notoriously rough discontinuation symptoms.
• MAOIs (Nardil, Parnate, Marplan): the highest-risk category. Combining these with psilocybin or ayahuasca can be dangerous. Most facilitators simply won't take you on until you've been off for a substantial period under a doctor's care.
• Tricyclics (amitriptyline, nortriptyline): mixed reports. Some sources suggest a potentiation of the experience rather than attenuation, but the safety profile is less studied and warrants caution.
• Bupropion (Wellbutrin): works on dopamine and norepinephrine, not serotonin, so the classic interaction concerns are lower. But it lowers the seizure threshold, which becomes relevant with any strong psychoactive.
• Lithium: taken with a classic psychedelic, lithium has been linked in case reports to seizures. This one is treated as a firm contraindication by most experienced facilitators.
• Benzodiazepines (Xanax, Ativan, Klonopin): don't cause serotonin problems but can blunt the experience significantly, and long-term users face their own tapering challenges.

None of the above is a prescription — literally. It's a summary of what the current literature and retreat community consensus suggest, and it changes as more research comes in. The specifics of your dose, your body, your other medications, and your history all shift the picture.

Can I Just Stop My Antidepressant Before the Retreat?

This is the question that lands in facilitator inboxes constantly, and the honest answer is: not on your own, and not casually. Discontinuation syndrome is real. Coming off an SSRI or SNRI abruptly can produce weeks of dizziness, brain zaps, insomnia, emotional volatility, and — for some people — a full return of the depression the medication was managing, sometimes worse than before.

A responsible taper is done with the prescriber who put you on the medication in the first place. Weeks, sometimes months, of stepping the dose down. Some people navigate it beautifully. Others discover their depression was more medication-dependent than they realized. Neither outcome is a failure — but discovering it two weeks before a booked ceremony in the jungle is a bad time to find out.

Here's the piece I wish more people considered before booking: you may not be a good candidate for a psychedelic retreat right now, and that's not a verdict on your future. If your medication is doing meaningful work stabilizing you, ripping it away to chase a mushroom experience can undo months of hard-won ground. Retreats will still be there next year. Your nervous system's stability is not a renewable resource you should gamble.

What Reputable Retreats Actually Require

A well-run psychedelic or plant-medicine retreat will send you a medical intake form that reads like a small novel. They'll ask about every prescription, over-the-counter medication, supplement, and recreational substance. They'll want dosages, duration, and the name of your prescribing doctor. Some require a signed letter from that doctor clearing you for participation.

If a retreat doesn't ask these questions, that's a red flag the size of a billboard. It means they're either negligent or willing to take on liability they shouldn't. Either way, not the container you want to be in when you're chemically vulnerable and hours from your ordinary reality.

Expect a good retreat to require:

1. A full disclosure of medications and mental-health history.
2. A documented taper period appropriate to your specific drug — typically 4–6 weeks off SSRIs, longer for fluoxetine, and case-by-case for the rest.
3. Sign-off from your prescriber, or at minimum evidence you've had the conversation.
4. A medical screening call, not just a form.
5. Clear protocols for what happens if something goes sideways mid-ceremony — trained medical personnel, benzodiazepine rescue meds on hand, evacuation plans.

What About Microdosing While on Antidepressants?

The microdosing question deserves its own paragraph because it comes up constantly. Subperceptual doses of psilocybin — the 0.1 to 0.3 gram range — theoretically pose less risk of the acute problems associated with a full ceremonial dose. But the theoretical part is doing a lot of work in that sentence. The research on chronic low-dose interactions with SSRIs is thin. Anecdotal reports on Reddit and elsewhere suggest people do it, but anecdotal reports also suggest people do all kinds of things without incident until they don't.

The more thoughtful position is: microdosing while on serotonergic antidepressants likely does something, we don't fully know what, and the people best positioned to answer the question — psychiatrists trained in psychedelic medicine — are still a small and geographically clustered group. If you can find one, talk to them. If you can't, err on the side of not experimenting on yourself with two active compounds whose interaction hasn't been mapped.

The Bigger Question Underneath

Most people asking about medication interactions are really asking a different question: am I too damaged, too medicated, too far into pharmaceutical territory to still benefit from plant medicine? The answer is no. Some of the most profound retreat stories I've heard came from people who spent a decade on antidepressants before they were ever ready — practically or medically — to try something else.

The path there just isn't the fastest one. It usually involves a slow, deliberate reworking of your medication regimen with a doctor who takes psychedelics seriously as a treatment modality (they exist, and there are more every year), a period of stabilization off medication before ceremony, and honest conversations with facilitators about your history. Rushed, this path gets people hurt. Patient, it opens doors that were previously locked.

If you're at the beginning of researching this and want to see what responsible facilitation actually looks like, a curated selection of psilocybin and plant-medicine retreats — the kind that ask the hard medical questions before taking your booking — can be browsed on our marketplace here. Read the intake requirements carefully. The retreats worth attending are the ones that might tell you to wait.